Akoya Biosciences Inc (AKYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 11,636 | N/A | N/A | N/A |
| Marketable Securities | 10,023 | N/A | N/A | N/A |
| Receivables | 13,167 | N/A | N/A | N/A |
| Inventories | 4,093 | N/A | N/A | N/A |
| TOTAL | $40,874 | $N/A | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 4,983 | N/A | N/A | N/A |
| Intangibles | 42,399 | 0 | 0 | 0 |
| Other Non-Current Assets | 1,157 | 0 | 0 | 0 |
| TOTAL | $48,539 | $N/A | $N/A | $N/A |
| Total Assets | $89,413 | $N/A | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 8,119 | 0 | 0 | 0 |
| Accrued Expenses | 8,581 | N/A | N/A | N/A |
| TOTAL | $21,155 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 24,466 | N/A | N/A | N/A |
| Deferred Revenues | 4,375 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 72,678 | 0 | 0 | 0 |
| TOTAL | $98,417 | $N/A | $N/A | $N/A |
| Total Liabilities | $119,572 | $N/A | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 1 | N/A | N/A | N/A |
| Retained earnings | -31,413 | N/A | N/A | N/A |
| Other shareholders' equity | 1,253 | 0 | 0 | 0 |
| TOTAL | $-30,159 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $89,413 | $0 | $0 | $0 |